MG53 suppresses IRF7 to reprogram macrophages and promote antitumor immunity in pancreatic ductal adenocarcinoma.
- DOI
- 10.1016/j.celrep.2026.118000
- Published
- 2026 Sep 16
- Container
- Cell reports
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.celrep.2026.118000,
title = {MG53 suppresses IRF7 to reprogram macrophages and promote antitumor immunity in pancreatic ductal adenocarcinoma.},
author = {Pei Y and Fang M and Zhang F and Zhao D and Li Y and Huang J and Liang X and Xiao RP and Liang T and Wu HK},
year = {2026},
journal = {Cell reports},
doi = {10.1016/j.celrep.2026.118000},
url = {https://doi.org/10.1016/j.celrep.2026.118000}
}RIS
TY - JOUR TI - MG53 suppresses IRF7 to reprogram macrophages and promote antitumor immunity in pancreatic ductal adenocarcinoma. AU - Pei Y AU - Fang M AU - Zhang F AU - Zhao D AU - Li Y AU - Huang J AU - Liang X AU - Xiao RP AU - Liang T AU - Wu HK PY - 2026 JO - Cell reports DO - 10.1016/j.celrep.2026.118000 UR - https://doi.org/10.1016/j.celrep.2026.118000 ER -
APA
Y, P., M, F., F, Z., D, Z., Y, L., J, H., X, L., RP, X., T, L., & HK, W. (2026). MG53 suppresses IRF7 to reprogram macrophages and promote antitumor immunity in pancreatic ductal adenocarcinoma.. Cell reports. https://doi.org/10.1016/j.celrep.2026.118000
Source records
- pubmed · retrieved 2026-09-26T21:19:19.636Z